VERU INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
VERU INC. (VERU) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $330.28 thousand for the 12-month period ending 2023-09-30, per its 10-K/A filed 2024-04-01.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2024-04-01
- VERU INC. effective income tax rate reconciliation, nondeductible expense, other, amount for the quarter ending 2019-09-30 was $1.12K, a 13.39% decline year-over-year.
- VERU INC. effective income tax rate reconciliation, nondeductible expense, other, amount for the quarter ending 2019-06-30 was $2.27K, a 163.23% increase year-over-year.
- VERU INC. effective income tax rate reconciliation, nondeductible expense, other, amount for the quarter ending 2019-03-31 was $2.36K, a 72.83% decline year-over-year.
- VERU INC. effective income tax rate reconciliation, nondeductible expense, other, amount for the quarter ending 2018-12-31 was $2.42K, a 39.50% decline year-over-year.
- VERU INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2023 was $330.28K, a 329.42% increase from fiscal 2022.
- VERU INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2022 was $76.91K, a 43.86% decline from fiscal 2021.
- VERU INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2021 was $137.00K, a 19.45% increase from fiscal 2020.
- VERU INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2020 was $114.70K, a 1303.73% increase from fiscal 2019.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 6 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 9 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2023-09-30 | $330.28K 10-K/A · filed 2024-04-01 | ||||
| 2022-09-30 | $76.91K 10-K/A · filed 2024-04-01 | ||||
| 2021-09-30 | $137.00K 10-K · filed 2022-12-05 | ||||
| 2020-09-30 | $114.70K 10-K · filed 2021-12-02 | ||||
| 2019-09-30 | $1.12K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-10 | $3.39K derived: sum of 2 quarters · filed 2020-12-10 | $5.75K derived: sum of 3 quarters · filed 2020-12-10 | $8.17K 10-K · filed 2020-12-10 | |
| 2019-06-30 | $2.27K 10-Q · filed 2019-08-08 | $4.63K derived: sum of 2 quarters · filed 2019-08-08 | $7.05K 10-Q · filed 2019-08-08 | $8.35K derived: sum of 4 quarters · filed 2019-12-12 | |
| 2019-03-31 | $2.36K 10-Q · filed 2019-05-15 | $4.78K 10-Q · filed 2019-05-15 | $6.08K derived: sum of 3 quarters · filed 2019-12-12 | $6.94K derived: sum of 4 quarters · filed 2019-12-12 | |
| 2018-12-31 | $2.42K 10-Q · filed 2019-02-13 | $3.71K derived: sum of 2 quarters · filed 2019-12-12 | $4.57K derived: sum of 3 quarters · filed 2019-12-12 | $13.28K derived: sum of 4 quarters · filed 2019-12-12 | |
| 2018-09-30 | $1.29K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $2.15K derived: sum of 2 quarters · filed 2019-12-12 | $10.86K derived: sum of 3 quarters · filed 2019-12-12 | $14.86K 10-K · filed 2019-12-12 | |
| 2018-06-30 | $862.00 10-Q · filed 2019-08-08 | $9.56K derived: sum of 2 quarters · filed 2019-08-08 | $13.56K 10-Q · filed 2019-08-08 | $214.56K derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-03-31 | $8.70K 10-Q · filed 2019-05-15 | $12.70K 10-Q · filed 2019-05-15 | $213.70K derived: sum of 3 quarters · filed 2019-05-15 | $223.70K derived: sum of 4 quarters · filed 2019-05-15 | |
| 2017-12-31 | $4.00K 10-Q · filed 2019-02-13 | $205.00K derived: sum of 2 quarters · filed 2019-02-13 | $215.00K derived: sum of 3 quarters · filed 2019-02-13 | $218.00K derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-09-30 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | $211.00K derived: sum of 2 quarters · filed 2018-12-13 | $214.00K derived: sum of 3 quarters · filed 2018-12-13 | $215.00K 10-K · filed 2018-12-13 | $27.00K 10-K · filed 2018-01-02 |
| 2017-06-30 | $10.00K 10-Q · filed 2018-08-14 | $13.00K derived: sum of 2 quarters · filed 2018-08-14 | $14.00K 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | $3.00K 10-Q · filed 2018-05-11 | $4.00K 10-Q · filed 2018-05-11 | |||
| 2016-12-31 | $1.00K 10-Q · filed 2018-02-14 | ||||
| 2016-09-30 | $50.00K 10-K · filed 2018-01-02 | ||||
| 2015-12-31 | $2.00K 10-Q · filed 2017-02-09 | ||||
| 2015-09-30 | $51.00K 10-K · filed 2018-01-02 | ||||
| 2014-09-30 | -$5.00K 10-K · filed 2016-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |